Država: Australija
Jezik: engleski
Izvor: Department of Health (Therapeutic Goods Administration)
ketorolac trometamol, Quantity: 30 mg/mL
Fresenius Kabi Australia Pty Ltd
Ketorolac trometamol
Injection, solution
Excipient Ingredients: ethanol; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide
Intramuscular
5 vials
(S4) Prescription Only Medicine
Ketorolac Kabi is indicated for the short-term management of moderately severe, acute pain following surgical procedures. The total duration of ketorolac use should not exceed five days.,It is recommended that ketorolac parenteral be used in the immediate post-operative period. Patients can then be converted to the oral formulation (dependent on their analgesic needs), as outlined in the "DOSE AND METHOD OF ADMINISTRATION" Section (Refer to "Conversion from Parenteral to Oral Therapy"). The total period of treatment utilising the oral and/or intramuscular route of administration is not to exceed five days.,General,Ketorolac is not recommended for use as an obstetrical pre-operative medication or for obstetrical analgesia because it has not been adequately studied for use in these circumstances and because the known effects of drugs that inhibit prostaglandin biosynthesis on uterine contraction and foetal circulation.,There is no satisfactory evidence for the use of ketorolac in acute exacerbations of chronic painful inflammatory conditions (e.g. rheumatoid or osteoarthritis).
Visual Identification: Clear, colourless to slightly yellow colour solution; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2017-04-28
Filename: cmi-clean Page 1 of 4 KETOROLAC KABI _Contains the active ingredient ketorolac trometamol _ _ _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Ketorolac Kabi. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using Ketorolac Kabi against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT KETOROLAC KABI IS GIVEN FOR Ketorolac Kabi belongs to a family of medicines called Non- Steroidal Anti-Inflammatory Drugs (NSAIDs). It contains the active ingredient Ketorolac Trometamol. Ketorolac Kabi relieves pain and reduces inflammation (swelling and soreness) that may occur following surgery. Although Ketorolac Kabi can relieve the symptoms of pain and inflammation, it will not cure your condition. Your doctor may have prescribed Ketorolac Kabi for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS WHY KETOROLAC KABI HAS BEEN PRESCRIBED FOR YOU. THIS MEDICINE IS AVAILABLE ONLY WITH A DOCTOR'S PRESCRIPTION. KETOROLAC KABI IS NOT ADDICTIVE. BEFORE YOU ARE GIVEN KETOROLAC KABI _When you must not use it _ _ _ DO NOT USE KETOROLAC IF: YOU HAVE AN ALLERGY TO: KETOROLAC OR ANY INGREDIENTS LISTED AT THE END OF THIS LEAFLET ASPIRIN OR ANY OTHER NSAID MEDICINE Many medicines used to treat headache, period pain and other aches and pains contain aspirin or NSAID medicines. If you are not sure if you are taking any of these medicines, ask your doctor or pharmacist. Symptoms of an allergic reaction to these medicines may include: asthma, wheezing or shortness of breath swelling of the face, lips or tongue which may cause difficulty in swallowing or breathing hives, itching or skin rash fainting If you are allergic to aspirin or NSAID me Pročitajte cijeli dokument
AUSTRALIAN PRODUCT INFORMATION- KETOROLAC KABI (KETOROLAC TROMETAMOL) SOLUTION FOR INJECTION Australian PI May 2018 Page 1 of 23 \ 1 NAME OF MEDICINE Ketorolac trometamol 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial of Ketorolac Kabi contains ketorolac trometamol 30 mg/ml (3%). Ketorolac trometamol is a member of the pyrrolo-pyrrole group of NSAIDs. The medicine is structurally and pharmacologically related to tolmetin and indomethacin, however, unlike these pyrrole acetic acid derivatives, ketorolac is a cyclic propionic derivative. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Ketorolac trometamol 30 mg/mL solution for injection: Clear and slightly yellow solution for injection WARNING Ketorolac is a potent NSAID analgesic and the resulting NSAID-related adverse effects can be serious, for example gastrointestinal haemorrhage, surgical haemorrhage and renal impairment. Increasing the dose of ketorolac beyond the recommendations in the product information will not provide better efficacy but will result in increasing risk of developing serious adverse effects. AUSTRALIAN PRODUCT INFORMATION- KETOROLAC KABI (KETOROLAC TROMETAMOL) SOLUTION FOR INJECTION Australian PI May 2018 Page 2 of 23 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ketorolac Kabi is indicated for the short-term management of moderately severe, acute pain following surgical procedures. The total duration of ketorolac use should not exceed five days. _It is recommended that ketorolac parenteral be used in the immediate post-operative period. _ _Patients can then be converted to the oral* formulation (dependent on their analgesic needs), as _ _outlined in the "DOSE AND METHOD OF ADMINISTRATION" Section (Refer to "Conversion from _ _Parenteral to Oral Therapy"). The total period of treatment utilising the oral and/or intramuscular _ _route of administration is not to exceed five days._ General Ketorolac is not recommended for use as an obstetrical pre-operative medication or for obstetrical a Pročitajte cijeli dokument